Thus, a non-peptide agonist specific for PKR1, called IS20, was developed to mimic the cardioprotective effects of PROK2 against heart failure developed by myocardial infarction (102) and anthracyclines (6) in mice. This evidence concerns the gene PROK2 and myocardial infarction.